Epsilon-3 Bio
Babraham, Cambridgeshire, United Kingdom
About Epsilon-3 Bio
Epsilon-3 Bio Ltd. is a preclinical stage company with investment from Index Ventures, Novo Ventures and Imperial Innovations. The company is focused on the efficient development of first in class drug candidates stimulating safe removal of cellular debris. Such agents are expected to provide a useful treatment for a wide range of diseases including inflammation and autoimmunity, neurodegeneration, fibrosis and cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2012)
- Website: e3bio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/epsilon-3-bio-2506520 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.